Drug Research

Resistance to historically effective antimalarial drugs has contributed to the resurgence of malaria across sub-Saharan Africa in the past decade. The recent discovery of parasitic resistance to Artemisinin monotherapies underscores the urgent need for new and more effective antimalarial treatments.

Medicines for Malaria Venture (MMV) is a non-profit organization created to discover, develop and deliver new antimalarial drugs through effective public-private partnerships. MMV does this by providing drug companies with supplmental funding, technical expertise and logistical support. It currently has over 20 new products in the pipeline.

For more information about Drug Research for malaria control, please visit MMV's website.

Must Read Malaria Keeps Killing Millions May 16, 2008 GlaxoSmithKline and Medicines For Malaria Venture announce new collaboration to investigate novel antimalarial compounds January 28, 2008 Newest Malaria Medicine May Be Losing Potency in Asia, WHO Says October 17, 2007 Certain Combination Therapy Found More Effective For Treating Malaria In African Children May 28, 2007 Scientists discover new compound that kills drug-resistant malaria February 12, 2007	AFM Articles AFM update on recent drug quality studies August 16, 2012 Medicine that is more placebo than cure July 12, 2012 Shelving malaria April 02, 2009 Malaria Drugs Shelf-Life Possibly Much Longer Than Expected February 26, 2009 Malaria Keeps Killing Millions May 16, 2008 » more...	News Falsified batches of Coartem recently circulating in Western and Central Africa May 14, 2013 Counterfeiting business hits $200 billion annually April 07, 2013 WHO Moves Regional Malaria Office to Cambodia January 22, 2013 Resistance in the fight against malaria December 04, 2012 New fight needed against killer malaria in Asia November 02, 2012 » more...
Research Travel and fake artesunate: a risky business September 22, 2012 Anti-infective medicine quality: analysis of basic product quality by approval status and country of manufacture July 16, 2012 Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005-2010 period June 15, 2012 Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa May 22, 2012 Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission April 18, 2012 » more...	Press Releases DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving Drugs June 24, 2008 Scientists discover new compound that kills drug-resistant malaria February 12, 2007 MissionMore than 4.3 million medicines tested thanks to calculation grids February 08, 2007 Novartis Institute for Tropical Diseases Inaugurates New Indonesian Research Initiative to Study Dengue fever, Tuberculosis and Malaria January 25, 2007	Events No Events found for this issue